Legend Biotech (LEGN) Retained Earnings (2019 - 2024)
Legend Biotech (LEGN) has disclosed Retained Earnings for 6 consecutive years, with $1.0 billion as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Retained Earnings fell 16.79% year-over-year to $1.0 billion, compared with a TTM value of $1.0 billion through Dec 2024, down 16.79%, and an annual FY2024 reading of $1.0 billion, down 16.79% over the prior year.
- Retained Earnings was $1.0 billion for Q4 2024 at Legend Biotech, down from $1.3 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.3 billion in Q4 2023 and bottomed at $597.7 million in Q4 2020.
- Average Retained Earnings over 5 years is $879.9 million, with a median of $766.0 million recorded in 2021.
- The sharpest move saw Retained Earnings surged 295.04% in 2020, then fell 16.79% in 2024.
- Year by year, Retained Earnings stood at $597.7 million in 2020, then increased by 28.16% to $766.0 million in 2021, then decreased by 2.87% to $744.0 million in 2022, then surged by 68.15% to $1.3 billion in 2023, then decreased by 16.79% to $1.0 billion in 2024.
- Business Quant data shows Retained Earnings for LEGN at $1.0 billion in Q4 2024, $1.3 billion in Q4 2023, and $744.0 million in Q4 2022.